Remote Labs are Coming of Age
If you are a biologist or a drug hunter and you haven’t read a blog by Dr. Vijay Pande, a …
Premium Content
Merging AI and Quantum Computing To Boost Drug Discovery
Quantum computing is a growing trend due to recent major advances in hardware making this technology a practically feasible thing. …
How Pharmaceutical Industry Is Adopting Artificial Intelligence To Boost Drug Research
What is “artificial intelligence”? Artificial intelligence (AI) is an interdisciplinary science concerned with building “intelligent agents”, the field which takes …
8 Notable AI Companies in Clinical Research to Watch in 2022
The clinical trial is a critical stage of drug development workflow, with an estimated average success rate of about 11% …
Will Biologics Surpass Small Molecules In The Pharmaceutical Race?
The first biologics drug, humanized insulin (5.8 kDa), became available in 1982 following the advent of biotechnology, and it marked …
The Explosion of Therapeutic Modalities: Small Molecules, Biologics, and Everything in Between
Since the early days of the pharmaceutical industry, small molecules have been the most extensively used group of drugs. Nowadays, …
A March of “Big Tech” Corporations Into Pharmaceutical Industry
In November 2021, the parent company of Google, Alphabet, Inc., announced the launch of a new commercial subsidiary in the …
A New Breed of Biotechs is Taking a Lead
A Hong Kong-based artificial intelligence (AI)-driven drug discovery company Insilico Medicine has just announced the appointment of Dr. Michelle Chen …
A Parade of AI-driven Biotechs Going Public in 2020-2021
Over 2020-2021 we have seen a remarkable parade of artificial intelligence (AI), focused on discovering novel therapeutics, going public. This …
Ups and Downs of Adenovirus and Adeno-Associated Virus Vectors in Gene Therapy
Gene therapy is still an investigational technique. Viruses are commonly used as vectors to deliver a needed gene to a …
Pharmaceutical AI in 2021: Key Developments So Far
Table of Contents: Introduction Artificial intelligence (AI) in drug discovery yields breakthroughs The abundance of venture capital, major funding …
Antisense Oligonucleotides Make Sense
Antisense oligonucleotides (ASOs) are short (about 12 to 25 nucleotides long), synthetic single strands of DNA or RNA that are …
Can The Mucosal Immunity Protect Against COVID-19?
Common vaccines are synonymous with injections and grant you systemic immunity. But the injection isn’t the only way to develop …
What are the ADC drugs?
The antibody-drug conjugates (ADCs) market continues to rise globally, but ADCs are not a new thing. Why has ADC been surging …
Top RNA Biotech Startups To Watch in 2021
RNA therapeutics at a glance For many years the focus of therapeutic developments and scientific research was directed at the …
Companies Driving Innovation To Fight Alzheimer’s Disease
The overall technological progress in medicine and the overall increase in the quality and safety of life, compared to even …
Powered by Venture Funding, the Microbiome Market is Ready for Mainstream
2020 was an unusual year, for the first time, venture funding for microbiome companies substantially exceeded grant funding for microbiome …
Contract Research Organizations Tap Into AI To Increase Value Proposition
A few decades ago, pharmaceutical giants did most of the discovery work in-house, along with every other work necessary to …
Major VC Rounds For AI-driven Biotechs in 2020
The ongoing COVID19 crisis forced biotech-oriented venture capitalists (VC) to somewhat slow down the pace of their usual deal-flow -- …
![[Interview] Hacking Metabolomics With AI To …](/files/blog/20200513_170730.1003_Olaris_teampic_waterfront.jpg)
[Interview] Hacking Metabolomics With AI To Improve Clinical Research
Personalized medicine has become a paradigm-shifting trend in healthcare - the hegemony of “one-size-fits-all” drugs is increasingly challenged by novel innovative …
